| President's Advisory Council for HIV/AIDS |
Committee, Work group, Advisory group, or Task Force |
CDC, HRSA, IHS, OASH, SAMHSA |
OD/DPCPSI/OAR |
The Presidential Advisory Council on HIV/AIDS (PACHA) provides advice, information, and recommendations to the Secretary of Health Human Services regarding programs, policies, and research to promote effective treatment, prevention, and cure of HIV, including considering common co-morbidities of those with HIV as needed to promote effective HIV prevention and treatment and quality services to persons living with HIV. |
| President's Emergency Plan for AIDS Relief (PEPFAR) Cervical Cancer Prevention Expert Task Force |
Committee, Work group, Advisory group, or Task Force |
CDC |
NCI, NIAID |
NCI participates with other US government agencies (Department of State, CDC, USAID, and others) on an expert task force to inform the development and oversight of cervical cancer prevention programs within the US President’s Emergency Plan for AIDS Relief (PEPFAR) initiative. The Department of State-convenes an Expert Task Force from experts from the CDC, NIH (NCI), and other US government agencies including Department of State, US Agency for International Development (USAID), Department of Defense, and Peace Corps to inform the development and oversight of cervical cancer prevention programs within the US President’s Emergency Plan for AIDS Relief (PEPFAR) initiative. The task force meets periodically to review progress and updates from focus countries in the PEPFAR cervical cancer prevention efforts, refines and updates guidance for screening and precancer treatment for implementing partners in target countries, and provides recommendations for procedures for quality assurance and adverse event monitoring and reporting. |
| President's Task Force on Environmental Health Risks and Safety Risks to Children |
Committee, Work group, Advisory group, or Task Force |
OASH, ACF, ASPR, ATSDR, CDC, FDA, SAMHSA |
NHLBI, NICHD, NIEHS, NIMH, NIMHD, OD/ECHO |
In 1997, President Clinton issued Executive Order 13045, calling for each federal agency to ensure that its policies, programs, activities, and standards address disproportionate risks to children that result from environmental health risks or safety risks.” EO13045 established the President’s Task Force on Environmental Health Risks and Safety Risks to Children (Task Force).The Task Force has addressed issues such as childhood asthma, unintentional injuries, lead poisoning, developmental disorders, childhood cancer, and climate change. The Task Force also recommended the initiation of a prospective cohort study, from birth to adulthood, to evaluate the effects of both environmental exposures on child health and human development. An interdepartmental working group of senior staff was established to support the work of the Task Force—the Senior Staff Steering Committee (Steering Committee). It is co-chaired by the U.S. Environmental Protection Agency (EPA) and the Department of Health and Human Services (HHS). Working together through the Task Force, the federal government can continue to protect current and future generations by understanding and preventing negative environmental health impacts and helping to ensure opportunities for the development of healthy, more resilient children. |
| President's Task Force on Environmental Health Risks and Safety Risks to Children, Subcommittee on Climate, Emergencies, and Disasters |
Committee, Work group, Advisory group, or Task Force |
ACF, ASPR, CDC, HRSA, OASH |
NHLBI, NICHD, NIEHS |
In 1997, President Clinton issued Executive Order 13045, calling for each federal agency to “ensure that its policies, programs, activities, and standards address disproportionate risks to children that result from environmental health risks or safety risks.” EO13045 established the President’s Task Force on Environmental Health Risks and Safety Risks to Children (Task Force). Subcommittee on Climate, Emergencies, and Disasters. The new Subcommittee on Climate, Emergencies, and Disasters within the PTFCEH aims to address current gaps in health protection, promotion and research related to children resulting or arising from climate change, public health emergencies, and disasters. Dr. Dixon is a Co-Chair. https://ptfceh.niehs.nih.gov/ |
| Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria |
Committee, Work group, Advisory group, or Task Force |
ASPR |
NIAID |
In March 2015, the Department of Health and Human Services (HHS) announced the establishment of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB). This Federal Advisory Committee (FACA) includes public voting members, non-voting liaison representatives from organizations and/or interest groups, and non-voting federal ex-officio members. PACCARB provides advice, information, and recommendations to the Secretary regarding programs and policies intended to support and evaluate the implementation of Executive Order 13676, including the National Strategy for CARB and the National Action Plan for CARB. PACCARB has been reauthorized until January 18, 2019 (based on its charter), through Executive Order 13811 on September 29, 2017. |
| President’s Task Force for Environmental Health and Safety Risks to Children |
Committee, Work group, Advisory group, or Task Force |
ASPR, ACF, CDC, HRSA, OASH, SAMHSA |
NIA, NIAID, NICHD, NIEHS, NIMHD, OD |
The President’s Task Force on Environmental Health Risks and Safety Risks to Children is the focal point for coordinating federal government efforts to explore, understand, and act together to improve children’s environmental health and safety. |
| Prevention Research Coordinating Committee |
Committee, Work group, Advisory group, or Task Force |
AHRQ, CDC, FDA, OASH, OS |
CC, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP, OD/DPCPSI/ODS, OD/DPCPSI/ORWH, OD/OLPA |
The NIH Prevention Research Coordinating Committee (PRCC) serves as a venue for exchanging information on recent scientific advances in disease prevention; examining the impact of new policies on research; planning new or discussing ongoing initiatives; and highlighting program accomplishments. As a trans-NIH, trans-agency committee, the PRCC provides a broad perspective on the current state-of-the-science and actively disseminates information about prevention-related activities sponsored by federal and non-federal organizations to the NIH Institutes and Centers. |
| Prioritization of compounds to be submitted for international scheduling at the WHO expert committee on drug dependence |
Committee, Work group, Advisory group, or Task Force |
FDA, SAMHSA |
NIDA |
Collaboration description: This group (representing NIDA, CDC, DEA, FDA, ONDCP, SAMHSA, and the State Department) meets once per year ahead of the World Health Organization’s Expert Committee on Drug Dependence (ECDD). This effort is headed by the FDA and seeks input from the other representatives on inclusion/exclusion of specific drugs to be recommended by the USA to the WHO for International Scheduling. The drugs recommended to the WHO would be considered the deliverables in this case. |
| Privacy Enhancing Technologies (PET) SubIPC |
Committee, Work group, Advisory group, or Task Force |
CDC, FDA |
NCI |
Working Group created for the development of Privacy-Enhancing Technologies |
| Probiotic and Prebiotic Working Group |
Committee, Work group, Advisory group, or Task Force |
FDA |
CC, CIT, CSR, FIC, NCATS, NCCIH, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM |
The Probiotic and Prebiotic Working Group (PPWG) is a trans-NIH effort formed in 2006 to identify gaps and challenges in prebiotic and probiotic research. Their goals include (1) facilitating interactions and collaborations among research scientists in the field of probiotics and prebiotics, (2) advancing prebiotic and probiotic research, and (3) understanding the role of gut microbiota and use of prebiotics and probiotics in health and disease. The working group strives to promote constructive interactions across NIH Institutes, Centers, and Offices, by disseminating real-time information and keeping PPWG members abreast of current and future activities occurring in the fields of probiotics and prebiotics. The group meets quarterly to form allied partnerships and collaborate on various pre- and probiotic activities. 2024 update: Trans - NIH workshop "Oral Microbiome in Health and Systemic Diseases" June 25, 2024. Workshop is led by DCP/NCIA paperhttps://events.cancer.gov/nci/oral-microbiome |